Clinical trial

Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence

NCT05679193

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-01-02

PhasePHASE2

Study timeline

Study start (actual)2023-01-02Date precision: day

Registry last updated2024-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

PropranololDRUG · verified · RxNorm: propranolol

Sponsors & collaborators

Oslo University Hospitallead sponsor

Ivar, Ragna og Morten Holes legat til fremme av kreftforskningen i Norgecollaborator

Fondsstiftelsen ved Oslo Universitetssykehuscollaborator

Mapped research locations

OsloNorway1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05679193 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.